May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...
May 7, 2024 — RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology ...
May 7, 2024 — HonorHealth Research Institute’s David G. Rizik, M.D., narrates and is a co-producer of a documentary ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...
May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...
May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...
May 6, 2024 — Teleflex Incorporate, a leading global provider of medical technologies, today announced that the Wattson ...
May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...
May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an ...
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...